Modulation of energy status and cytotoxicity induced by FK506 and cyclosporin A in a renal epithelial cell line

Archives of Toxicology

Volumn 71, Issue 8, 1997, Pages 529-531

  Massicot, France ^a   Martin, Chantal ^a   Dutertre Catella, Hélène ^a   Ellouk Achard, Sophie ^a   Pham Huy, Chuong ^a   Thevenin, Marc ^a   Rucay, Pierre ^b   Warnet, Jean Michel ^a   Claude, Jean Roger ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL PAUL BROUSSE   (France)

Author keywords

ATP; Cyclosporin A; FK506; LLC PK1 cells; Nephrotoxicity

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYCLOSPORIN A; TACROLIMUS;

ANIMAL CELL; ARTICLE; CELL ENERGY; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; KIDNEY EPITHELIUM; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMALS; CELL SURVIVAL; CYCLOSPORINE; ENERGY METABOLISM; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LLC-PK1 CELLS; NUCLEOTIDES; SWINE; TACROLIMUS; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

ANIMALIA;

EID: 0030787419     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002040050423     Document Type: Article

References (14)

1. Atkinson DE (1968) The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 7: 4030-4034
2. Demetris AJ, Fung JJ, Todo S, Shapiro R, Starzl M (1992) Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy. A clinicopathological study of 96 patients. Transplantation 53: 1056-1062
3. Ellouk-Achard S, Pham-Huy C, Martin C, Massicot F, Dutertre-Catella H, Thevenin M, Rucay P, Duc HT, Warnet JM, Claude JR (1994) Comparative effects of FK506 and cyclosporin A on cell viability, ATP and calcium content in non-induced or induced rat hepatocytes in primary culture. Toxicol Lett Suppl 1: 22-23
4. Lehninger AL (1982) Biosynthesis of amino acids and nucleotides. In: Lehninger AL (ed) Principles of biochemistry. Worth Publishers, New York
5. Massicot F, Thevenin M, Martin C, Warnet J-M, Dutertre-Catella H, Claude JR (1994) Effects of cyclosporin on kidney glutathione metabolism and cytochrome P-450 in the rabbit: possible implication of eicosanoid metabolism. Drug Chem Toxicol 17: 449-462
6. Massicot F, Lamouri A, Pham-Huy C, Martin C, Heymans F, Warnet J-M, Godfroid JJ, Claude JR (1996) Preventive effects of two PAF-antagonists, PMS 536 and PMS 549 on cyclosporin A (CsA)-induced oxidative injury. European Society for Biochemical Pharmacology, 14th European Workshop on Drug Metabolism, July 3-8, Université René-Descartes, Paris, France
7. Miller WL, Thomas RA, Berne RM, Rubio R (1978) Adenosine production in the ischaemic kidney. Circ Res 43: 390-397
8. Morris RE (1996) Mechanisms of action of new imunosuppressive drugs. Kidney Int 49 (Suppl) 53: 526-538
9. Nalesnik MA, Lai HS, Murase N, Todo S, Starzl T (1990) The effect of FK506 and cyclosporin A on the Lewis rat renal ischaemia model. Transplant Proc 22 (Suppl 1): 87-89
10. Pfielschifter J, Ruegg UT (1987) Cyclosporine A augments angiotensin II stimulated rise in intracellular free calcium in vascular smooth muscle. Biochem J 248: 883-887
11. Pham-Huy C, Martin C, Thevenin M, Warnet JM, Ellouk S, Massicot F, Dutertre-Catella H, Claude JR (1993) Determination of ATP, ADP, AMP and other nucleotides in tissues and cell culture by HPLC. Pharmacol Toxicol 73 (Suppl 11): 120
12. Walker RJ, Duggin GG (1992) Cellular mechanisms of drug nephrotoxicity. In: Seldin DW, Giebish G (eds) The kidney: physiology and pathophysiology, 2nd edn. Raven Press, New York, pp 3571-3595
13. Wallemacq PE, Reding R (1993) FK506 (Tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects. Clin Chem 39: 2219-2228
14. Wu YM, Venkataramanan R, Suzuki M, Zhu Y, Abdallah H, Emeigh J, Burckart GJ, Warty VS, Fung JJ, Todo S, Starzl TE (1991) Interaction between FK506 and cyclosporin in dogs. Transplant Proc 23: 2797-2792